<DOC>
	<DOCNO>NCT01484093</DOCNO>
	<brief_summary>Mantle cell lymphoma ( MCL ) rare aggressive type lymphoma , 3,000 case diagnose per year . MCL consider difficult cancer treat . This study do well understand treat MCL .</brief_summary>
	<brief_title>Sequential Chemo-Radioimmunotherapy Followed Autologous Transplantation Patients With Untreated Advanced Stage Mantle Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<criteria>Previously untreated advanced stage mantle cell lymphoma ( Clinical stage 2 abdominal involvement , stage 3 stage 4 ) . Histologic diagnosis confirm MSKCC pathologist mantle cell lymphoma Cyclin D1 , D2 and/or , D3 stain perform . Presence measurable disease determine FDGPET , CT , endoscopy , colonoscopy , bone marrow biopsy . Ages 1870 . Transplant eligibility confirm Disease Management Team . KPS ≥ 70 % . Adequate organ function : WBC ANC ≥ 1000 cells/mcL platelet count ≥ 100,000 cells/mcL unless felt secondary underlying mantle cell lymphoma count permissible . Adequate renal function determine Cr &lt; = 1.5 mg/dL 24 hr creatinine clearance ≥ 50 ml/hr Adequate hepatic function determine total bilirubin &lt; = 1.5x ULN ( unless know Gilbert syndrome ) AST &lt; = 5.0x ULN . Cardiac ejection fraction great equal 50 % determine echocardiogram MUGA . For patient ≥ age 60 , stress echocardiogram require , requirement . DLCO great equal 50 % determine pulmonary function test perform prior initiation treatment . Patients positive Hepatitis B serology treat per institutional guideline . Prior treatment mantle cell lymphoma , include 7 day steroid , immunotherapy , radioimmunotherapy , chemotherapy . This include patient initiated RCHOP outside institution within 2 week enrollment . Patients use &gt; = 10mg/day steroid chronic medical condition Pregnant breastfeeding . Note : Premenopausal patient must negative , serum HCG within 14 day enrollment , . HIV positive Hepatitis C antibody positive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>CYCLOPHOSPHAMIDE ( CYTOXAN )</keyword>
	<keyword>CYTARABINE ( ARA-C )</keyword>
	<keyword>DOXORUBICIN/ADRIAMYCIN</keyword>
	<keyword>PREDNISONE</keyword>
	<keyword>RITUXIMAB</keyword>
	<keyword>TOSITUMOMAB ( BEXXAR )</keyword>
	<keyword>Iodine</keyword>
	<keyword>VINCRISTIN</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Chemo-Radioimmunotherapy</keyword>
	<keyword>Autologous Transplantation</keyword>
	<keyword>Untreated</keyword>
	<keyword>11-095</keyword>
</DOC>